Biltmore Family Office’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Hold |
101,467
| – | – | 0.04% | 204 |
|
|
2025
Q1 | $223K | Hold |
101,467
| – | – | 0.04% | 195 |
|
|
2024
Q4 | $155K | Buy |
+101,467
| New | +$155K | 0.03% | 208 |
|
|
2023
Q4 | – | Sell |
-16,425
| Closed | -$16.9K | – | 237 |
|
|
2023
Q3 | $16.9K | Hold |
16,425
| – | – | ﹤0.01% | 213 |
|
|
2023
Q2 | $19.1K | Buy |
16,425
+125
| +0.8% | +$145 | ﹤0.01% | 210 |
|
|
2023
Q1 | $24.6K | Buy |
+16,300
| New | +$24.6K | 0.01% | 249 |
|